{"date_created":"2011-01-25","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000033691.0"],"variation_id":"12610","interpretation_date_last_evaluated":"2008-03-15","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000033691","interpretation_comments":[],"local_key":"190020.0011_COSTELLO SYNDROME","id":"SCV000033691","variation_archive_id":"VCV000012610","internal_id":"33691","version":"2","title":"HRAS, THR58ILE_COSTELLO SYNDROME","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-12-15","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506439","clinical_assertion_observation_ids":["SCV000616365.0"],"variation_id":"12610","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2017-04-03","submission_id":"506439.2019-02-25","clinical_assertion_trait_set_id":"SCV000616365","interpretation_comments":["{\"text\":\"The c.173C\u003eT (p.Thr58Ile) variant in HRAS has been reported in the literature as an unconfirmed de novo occurrence in a patient with clinical features of a RASopathy (PM6; PMID 20112233, 16474405). Also, at least 2 independent occurrences of this variant have been detected in patients with a RASopathy (PS4_Supporting; PMID: 22488832, 18247425, 23321623, 20949621, 16921267). This variant was absent from large population studies (PM2; ExAC, http://exac.broadinstitute.org). The p.Thr58Ile variant in HRAS is analogous to the same previously established amino acid change in the KRAS gene and the ClinGen RASopathy Expert Panel has defined that the pathogenicities of analogous variants in the HRAS and KRAS genes are correlated based on the assumption that a known functional residue in one gene is equivalent to other functions within that subgroup (PS1; 29493581). Furthermore, the variant is in a location that has been defined by the ClinGen RASopathy Expert Panel to be a mutational hotspot or domain of HRAS (PM1; PMID 29493581). The variant is in HRAS, which has been defined by the ClinGen RASopathy Expert Panel as a gene with low rate of benign missense with missense variants commonly being pathogenic (PP2; PMID 29493581). Computational prediction tools and conservation analysis suggest that the p.Thr58Ile variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for RASopathies in an autosomal dominant manner. Rasopathy-specific ACMG/AMP criteria applied (PMID:29493581): PM6, PS4_Supporting, PM2, PS1, PM1, PP2, PP3.\",\"type\":\"public\"}"],"content":"{\"@FDARecognizedDatabase\":\"true\",\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ClinGen RASopathy ACMG Specifications v1\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/60rptlbs/clingen_rasopathy_acmg_specifications_v1.pdf\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20949621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16474405\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20112233\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16921267\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23321623\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4fa14d9d-3bce-4dd8-affa-771b6298c4fc\"}}]}}","local_key":"4fa14d9d-3bce-4dd8-affa-771b6298c4fc|Orphanet:ORPHA3071","id":"SCV000616365","variation_archive_id":"VCV000012610","internal_id":"1202773","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"reviewed by expert panel","submission_names":["SUB5222244"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000062127.0"],"variation_id":"12610","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2014-09-23","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000062127","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinical features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated with disease in one affected relative from one of these families. This variant was absent from large population studies. Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM).\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}}]}}","local_key":"26351883|OMIM:218040","id":"SCV000062127","variation_archive_id":"VCV000012610","internal_id":"103327","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2014-10-17","rcv_accession_id":"RCV000144573","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505209","clinical_assertion_observation_ids":["SCV000189872.0"],"variation_id":"156482","interpretation_date_last_evaluated":"2014-07-24","submission_id":"505209.2014-08-08","clinical_assertion_trait_set_id":"SCV000189872","interpretation_comments":[],"content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8990002\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9298819\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11247896\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15459959\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20564245\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23159591\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_000038.5:c.1744-2A\u003eG|OMIM:175100","id":"SCV000189872","variation_archive_id":"VCV000156482","internal_id":"337561","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2015-04-03","rcv_accession_id":"RCV000157119","record_status":"current","interpretation_description":"Likely benign","submitter_id":"505401","clinical_assertion_observation_ids":["SCV000212147.0"],"variation_id":"180280","submission_id":"505401.2015-03-03","clinical_assertion_trait_set_id":"SCV000212147","interpretation_comments":[],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Submitter's publication\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26036859\",\"@Source\":\"PubMed\"}}}],\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"26036859\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"26036859\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26036859\",\"@Source\":\"PubMed\"}}}}","local_key":"NC_000002.11:g.21233102_21233104del|OMIM:143890","id":"SCV000212147","variation_archive_id":"VCV000180280","internal_id":"399997","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7435","review_status":"criteria provided, single submitter","submission_names":[]}
{"date_created":"2018-04-13","rcv_accession_id":"RCV000181039","record_status":"current","interpretation_description":"Likely benign","submitter_id":"505816","clinical_assertion_observation_ids":["SCV000740414.0"],"variation_id":"180280","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-07-06","submission_id":"505816.2017-08-02","clinical_assertion_trait_set_id":"SCV000740414","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"9114001|not provided","id":"SCV000740414","variation_archive_id":"VCV000180280","internal_id":"1444204","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["20170802-356"]}
{"date_created":"2018-02-16","rcv_accession_id":"RCV000776056","record_status":"current","interpretation_description":"Likely benign","submitter_id":"505849","clinical_assertion_observation_ids":["SCV000687254.0"],"variation_id":"180280","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-07-07","submission_id":"505849.2017-12-21","clinical_assertion_trait_set_id":"SCV000687254","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"Db4KrQBSZeoE7-orUyypkVzWd2QN_bUgt4mqBdD4Wik|MedGen:C0020445","id":"SCV000687254","variation_archive_id":"VCV000180280","internal_id":"1344550","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"10706","review_status":"criteria provided, single submitter","submission_names":["Color Genomics - ClinVar Submission - December 2017 -"]}
{"date_created":"2018-07-06","rcv_accession_id":"RCV000157119","record_status":"current","interpretation_description":"Likely benign","submitter_id":"505989","clinical_assertion_observation_ids":["SCV000782873.0"],"variation_id":"180280","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-01-02","submission_id":"505989.2018-04-09","clinical_assertion_trait_set_id":"SCV000782873","interpretation_comments":[],"content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}]}","local_key":"GL14439b|OMIM:143890","id":"SCV000782873","variation_archive_id":"VCV000180280","internal_id":"1525456","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7435","review_status":"criteria provided, single submitter","submission_names":["SUB3887192"]}
{"date_created":"2018-05-18","rcv_accession_id":"RCV000776056","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"506189","clinical_assertion_observation_ids":["SCV000748125.0"],"variation_id":"180280","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-03-01","submission_id":"506189.2017-07-28","clinical_assertion_trait_set_id":"SCV000748125","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Comment\":{\"$\":\"Variant present in the database from Uruguay\",\"@Type\":\"public\"}}","local_key":"g.38845_38847del","id":"SCV000748125","variation_archive_id":"VCV000180280","internal_id":"1456814","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"10706","review_status":"criteria provided, single submitter","submission_names":["IBeroAmerican FH Network"]}
{"date_created":"2017-04-07","rcv_accession_id":"RCV000181039","record_status":"current","interpretation_description":"Benign","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000538311.0"],"variation_id":"180280","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-03-28","submission_id":"21766.2017-04-03","clinical_assertion_trait_set_id":"SCV000538311","interpretation_comments":["{\"text\":\"Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 1.9% (122/6498) Finnish chromosomes\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","local_key":"67516603|not specified","id":"SCV000538311","variation_archive_id":"VCV000180280","internal_id":"1049374","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["GenomeExome_3.17.2017"]}
